NLS Pharmaceutics AG's activity chart (see below) currently has 3 price targets and 5 ratings on display.
Analysts' price targets on this stock were met 66.67% of the time, taking 678 days on average.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 14-Sep-2023. First documented stock forecast 12-Mar-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Sep-2023
$160
3 years 2 months 7 days ago
(14-Sep-2023)
1/1 (100%)
$-204.08 (-56.05%)
343
Buy Since 06-Sep-2022
$6
4 years 2 months 15 days ago
(06-Sep-2022)
0/1 (0%)
$-234.04 (-97.50%)
Buy Since 12-Mar-2021
$12
5 years 8 months 9 days ago
(12-Mar-2021)
1/1 (100%)
$-2328 (-99.49%)
1691
What is NLSP (NLS Pharmaceutics AG) average time for price targets to be met?
Which analyst most recently updated their price target on NLSP (NLS Pharmaceutics AG)?
Which analyst has the lowest performance score on NLSP (NLS Pharmaceutics AG) with a proven track record?
Which analyst has the most public recommendations on NLSP (NLS Pharmaceutics AG)?
Which analyst is the currently most bullish on NLSP (NLS Pharmaceutics AG)?
Which analyst is the currently most reserved on NLSP (NLS Pharmaceutics AG)?